RT info:eu-repo/semantics/article
T1 Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery
A1 The 2017 European Society of Coloproctology (ESCP) collaborating group
K1 Cáncer
K1 Cáncer de recto
K1 Quimioterapia
K1 Cirugía
K1 Rectal surgery, rectal cancer, pathology, radiology, neoadjuvant therapy, surgical oncology, deferral of surgery
K1 Rectal surgery
K1 Rectal cancer
K1 Pathology
K1 Radiology
K1 Neoadjuvant therapy
K1 Surgical oncology
K1 Deferral of surgery
K1 Cirugía
AB The mainstay of management for locally advanced rectal cancer is chemoradiotherapy followed by surgical resection. Following chemoradiotherapy, a complete response may be detected clinically and radio-logically (cCR) prior to surgery or pathologically after surgery (pCR). We aim to report the overall complete pathological response (pCR) rate and the reliability of detecting a cCR by conventional pre-operative imaging.
PB Wiley Online Library
SN 1462-8910
YR 2018
FD 2018
LK https://uvadoc.uva.es/handle/10324/79041
UL https://uvadoc.uva.es/handle/10324/79041
LA eng
NO Colorectal Disease. 2018; 20:58-68.
NO Producción Científica
DS UVaDOC
RD 10-dic-2025